Actionable news
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

Sarepta Therapeutics (SRPT) Stock Falls on Q2 Earnings Loss

NEW YORK (TheStreet) -- Shares of Sarepta Therapeutics (SRPT) are down 2.41% to $20.63 this morning after the company reported a loss for the 2016 second quarter, meeting analysts' expectations.

The company reported a loss of $1.19 per share, or $54.8 million total. No revenue was recognized for the 2016 second quarter.

Analysts had estimates the losses.

Sarepta is a Cambridge, MA-based biopharmaceutical company.

The company is currently waiting for an FDA decision for a Duchenne muscular dystrophy drug...